Xeris Biopharma Holdings, Inc. (XERS)

NASDAQ: XERS · Real-Time Price · USD

6.01

-0.23 (-3.69%)

At close: May 18, 2026, 4:00 PM EDT

6.04

+0.03 (0.50%)

After-hours: May 18, 2026, 7:29 PM EDT

Xeris Biopharma Holdings Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May '26 May 18, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	1,038	1,305	507	325	181	366
Market Cap Growth	40.87%	157.58%	56.05%	79.10%	-50.46%	24.75%
Enterprise Value	1,184	1,446	685.21	477.85	255.75	351.51
Last Close Price	6.01	7.85	3.39	2.35	1.33	2.93
PE Ratio	93.76	2447.71	-9.16	-5.22	-1.90	-1.89
Forward PE	47.43	64.50	-	-	-	-
PS Ratio	3.30	4.47	2.49	1.98	1.64	7.38
PB Ratio	79.71	95.32	-17.10	-47.86	4.01	3.84
P/TBV Ratio	80.23	99.06	-16.80	-47.70	3.99	2.43
P/FCF Ratio	21.84	46.72	-13.38	-6.59	-1.75	-3.79
P/OCF Ratio	21.38	45.58	-13.70	-6.90	-1.76	-3.83
EV/Sales Ratio	3.76	4.95	3.37	2.92	2.32	7.09
EV/EBITDA Ratio	24.63	39.02	-31.76	-15.08	-3.67	-3.10
EV/EBIT Ratio	32.99	58.07	-20.37	-10.86	-3.12	-3.05
EV/FCF Ratio	24.92	51.76	-18.10	-9.70	-2.47	-3.64
Debt / Equity Ratio	19.39	18.40	-8.45	-33.28	4.35	0.92
Debt / EBITDA Ratio	5.38	6.97	-12.58	-7.23	-2.84	-0.78
Debt / FCF Ratio	5.44	9.24	-7.17	-4.65	-1.91	-0.91
Net Debt / Equity Ratio	11.28	10.74	-6.75	-23.11	1.68	-0.15
Net Debt / EBITDA Ratio	3.05	3.97	-9.26	-4.95	-1.09	0.13
Net Debt / FCF Ratio	3.09	5.27	-5.28	-3.18	-0.74	0.15
Asset Turnover	0.81	0.83	0.63	0.49	0.34	0.21
Inventory Turnover	0.62	0.73	0.85	0.90	1.06	1.01
Quick Ratio	1.42	1.48	1.12	1.17	2.08	1.52
Current Ratio	2.12	2.19	1.67	1.64	2.54	1.80
Return on Equity (ROE)	89.95%	-6.96%	301.32%	-324.20%	-134.83%	-190.28%
Return on Assets (ROA)	9.26%	7.05%	-10.01%	-12.93%	-24.88%	-49.69%
Return on Invested Capital (ROIC)	20.73%	14.34%	-17.21%	-24.28%	-58.07%	-188.24%
Return on Capital Employed (ROCE)	13.12%	10.03%	-14.95%	-17.66%	-33.03%	-64.65%
Earnings Yield	1.16%	0.04%	-10.91%	-19.15%	-52.63%	-52.90%
FCF Yield	4.58%	2.14%	-7.47%	-15.18%	-57.06%	-26.41%
Buyback Yield / Dilution	-19.55%	-17.69%	-6.61%	-1.51%	-71.62%	-85.32%
Total Shareholder Return	-19.55%	-17.69%	-6.61%	-1.51%	-71.62%	-85.32%

Updated May 7, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q